0.9873USD+16.15%Mkt Cap: 10.40M USDP/E: —Last update: 2026-06-01
20/20 Biolabs, Inc. develops and commercializes AI-powered, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases. It provides OneTest for Cancer, a multi-cancer early detect…
Industry Peers
Medical Devices152.01BUSDP/E 24.4
115.59BUSDP/E 34.9
71.08BUSDP/E 20.0
54.41BSEKP/E 101.6
52.05BDKKP/E 22.0
51.03BUSDP/E 47.9
50.55BSEKP/E 21.4
38.34BEURP/E 18.1
Indicators:|
Key Statistics
Company
Market Cap10.40M USD
Enterprise Value6.11M USD
Revenue (TTM)1.84M USD
Gross Profit604.54K USD
Net Income (TTM)-3.74M USD
Revenue/Share0.1770 USD
Last Price0.9873 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees4
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-1.56
EV/Revenue3.31
P/S4.99
P/B3.55
EPS (TTM)-0.49
EPS (Forward)—
52W Range
0.83000% of range50.00
52W High50.00 USD
52W Low0.8300 USD
Profitability
Gross Margin29.56%
Oper. Margin-408.45%
EBITDA Margin-212.60%
Profit Margin-182.82%
ROE19447.70%
ROA-90.37%
Growth
Revenue Growth-36.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.92M USD
CapEx (TTM)—
FCF Margin-70.58%
FCF Yield-12.52%
Net Debt-3.29M USD
Net Debt/EBITDA0.84
Balance Sheet
Debt/Equity-70.67
Current Ratio1.82
Quick Ratio1.71
Book Value/Sh0.2440 USD
Cash/Share0.3980 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.0 (Buy)
Target (Mean)5.000 USD
Target Range5.000 USD – 5.000 USD
# Analysts1
Ownership
Shares Out.10.61M
Float8.69M
Insiders34.73%
Institutions2.83%
Short Interest
Short Ratio0.3d
Short % Float0.21%
Short % Out.0.17%
Shares Short18.05K
Short (prev mo.)18.94K
Technical
SMA 501.597 (-38.2%)
SMA 2002.666 (-63.0%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)399.86K
Avg Vol (10d)1.05M
Technical Indicators
RSI (14)14.1
MACD-0.3179
MACD Signal-0.3418
MACD Hist.+0.0239
BB Upper1.697 USD
BB Middle1.279 USD
BB Lower0.8606 USD
BB Width65.43%
ATR (14)0.1850 USD
Vol Ratio (20d)0.48x